American College of Clinical Pharmacy
      Search      Cart
         

Clinical Reasoning Series in Pediatric Pharmacy, 2017 Home Study Edition





Pediatric Asthma: Beyond the Guidelines

 

Series Overview

Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved for the recertification of the Board Certified Pediatric Pharmacy Specialist (BCPPS) and Board Certified Ambulatory Care Pharmacist (BCACP).

 

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

 

Program Content

“Pediatric Asthma: Beyond the Guidelines” will evaluate pharmacologic treatment options for patients who present pediatric asthma. Attendees will gain skills in evaluating the published literature concerning the management of pediatric asthma and in designing an individualized, evidence‐based therapeutic plan for managing patients with pediatric asthma. The program will also examine treatment options for patients with pediatric asthma.

 

“Pediatric Asthma: Beyond the Guidelines” covers the following content:

  • Overview of Pathophysiology and Monitoring of the Difficult to Control Pediatric Asthma Patient
  • Alternative Treatment Strategies for the Pediatric Asthma Patient
  • Pharmacogenomic Variants in Asthma
  • Applying Alternative Treatments to the Difficult to Treat Patient
  • Status Asthmaticus – Beyond Basic Treatment and Patient Case Discussion
  • Adherence Strategies for Pediatric Asthma Patients
  • Use of Technology to Assist in Pediatric Asthma Management
Faculty
Elizabeth Autry, Pharm.D., BCPPS Elizabeth Autry, Pharm.D., BCPPS
Pediatric Clinical Pharmacist
University of Kentucky HealthCare
Lexington, Kentucky
Erin J. McDade, Pharm.D., BCPPS Erin J. McDade, Pharm.D., BCPPS
Clinical Pharmacy Specialist – Pediatric Pulmonary Medicine
Texas Children’s Hospital
Houston, Texas
Jean Moon, Pharm.D., BCACP Jean Moon, Pharm.D., BCACP
University of Minnesota College of Pharmacy
Minneapolis, Minnesota
Susan Warrington, Pharm.D., BCPPS Susan Warrington, Pharm.D., BCPPS
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

 

Target Audience and Program Goals

Clinical pharmacists, BCPPSs & BCACPs providing care to patients with pediatric asthma.

 

At the conclusion of the program, the participant should be able to:

  1. Design an individualized, evidence-based therapeutic plan for managing a pediatric asthma patient who has not responded to asthma guideline recommended therapy;
  2. Identify and critically evaluate pharmacologic treatment options for the pediatric status asthmaticus patient who has failed standard treatment;
  3. Discuss pharmacogenomic variants that can impact patient response to asthma medications;
  4. Evaluate published literature to support the use of alternative pharmacotherapy options for the treatment of pediatric asthma patients; and
  5. Compare and contrast different medication adherence strategies for pediatric asthma patients.

 

Continuing Pharmacy Education Credit

ACPE The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-17-165-H01-P.

 

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 10, 2020. Partial credit is not available for this activity.

BCPPS and BCACP Specialty Recertification Credit

To be eligible for 6.0 CPE hours of recertification credit, BCPPSs and BCACPs must attend all 6.0 contact hours of live programming and successfully complete a Web‐based posttest by December 31, 2017. Partial credit is not available for this activity.

 

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

Technical Requirements

Requires an Internet browser and Adobe Reader.
 

Fees
Description Price Nonmember Cart
Specialty Recertification Program with 6.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is December 31, 2017.
$250 $365 Expired
Online Program with 6.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed. under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 10, 2020.
$199 $315